PBMC Culture & Immunology Assays — Serum Selection Guide
Peripheral blood mononuclear cells (PBMCs) are the primary cell system for human immunology research — covering T cell, B cell, NK cell, monocyte and dendritic cell biology. PBMC-based assays are used in vaccine immunogenicity studies, immunomonitoring in clinical trials, CAR-T potency testing, ADCC and CDC assays, and infectious disease research. Serum quality is the single most variable factor in PBMC assay reproducibility — endotoxin in the culture medium activates monocytes non-specifically, creating background cytokine secretion and cell activation that can invalidate entire experiments.
PBMC Assay Types — Serum Requirements
| Assay Type | Recommended Serum | Why | Concentration |
|---|---|---|---|
| IFN-γ ELISpot (vaccine immunogenicity) | FBS Very Low Endotoxin ≤1 EU/mL or Human Serum AB HI | Endotoxin activates monocytes via TLR4 → non-specific IFN-γ spots. Human serum preferred for vaccine immunogenicity — species-matched matrix. | 5–10% |
| Granzyme B / Perforin ELISpot (CTL function) | FBS Very Low Endotoxin ≤1 EU/mL | Endotoxin activates NK cells non-specifically via monocyte IL-12 — creates background degranulation spots independent of antigen-specific stimulation. | 5–10% |
| Multiplex cytokine assay (Luminex, MSD) | FBS Very Low Endotoxin ≤1 EU/mL | Endotoxin drives monocyte IL-6, TNF-α, IL-1β production — directly elevates baseline cytokine levels in unstimulated controls. | 5–10% |
| T cell proliferation assay (CFSE, Ki67) | FBS Very Low Endotoxin ≤1 EU/mL or Human Serum AB HI | Endotoxin causes bystander T cell activation — inflates background proliferation in unstimulated wells. | 5–10% |
| NK cell cytotoxicity (ADCC, CD107a degranulation) | FBS Very Low Endotoxin ≤1 EU/mL + FBS Ultra Low IgG <5 µg/mL for ADCC | Endotoxin activates NK cells non-specifically. Bovine IgG in standard FBS occupies FcγRIII (CD16) — reduces ADCC signal. | 5–10% |
| Monocyte / DC maturation assay | FBS Very Low Endotoxin ≤1 EU/mL | Monocytes are exquisitely sensitive to LPS — endotoxin in standard FBS drives spontaneous maturation and CD80/CD86 upregulation independent of experimental stimuli. | 5–10% during differentiation; serum-free during stimulation for maximum sensitivity |
| Opsonophagocytosis assay (OPA) | Human Serum AB OTC (native) as complement + opsonin source | OPA requires human complement and human IgG working together — bovine serum does not replicate human opsonisation. | 10–25% as complement/opsonin source |
| Regulatory T cell (Treg) suppression assay | FBS Very Low Endotoxin ≤1 EU/mL | Endotoxin activates effector T cells and impairs Treg suppressive function measurement — endotoxin-free serum critical for accurate Treg:Teff ratio determination. | 5–10% |
Human Serum vs FBS for PBMC Assays
The choice between FBS and Human Serum for PBMC assays depends on whether the assay requires physiological relevance to the human immune environment or whether cost-effective endotoxin-controlled culture is sufficient.
| Criterion | FBS Very Low Endotoxin | Human Serum AB HI |
|---|---|---|
| Species match | Bovine — xenogenic matrix | Human — physiological match for human immune cells |
| Endotoxin | ≤1 EU/mL — controlled | Tested — low endotoxin lot selection |
| Complement | Present in non-HI — use HI FBS for PBMC | Destroyed by 56°C/30 min HI — no spontaneous lysis |
| Cytokine background | Low with VLE grade | Lower — no bovine cytokine cross-reactivity |
| Vaccine immunogenicity ELISpot | Acceptable | Preferred — human matrix reflects in vivo conditions |
| Cost | Lower | Higher — but gold standard for clinical immunology |
| Donor variability | Lot-to-lot FBS variability | Pool variability — AB Male donors recommended for consistency |
BSA in Immunology Assays
| Application | Product | Concentration | Function |
|---|---|---|---|
| ELISA blocking buffer (cytokine detection) | BSA Low Endotoxin ≤5 EU/mg | 1–3% in PBS-T | Blocks non-specific binding in cytokine ELISA — low endotoxin critical to avoid cell activation during blocking |
| Flow cytometry staining buffer | BSA Low Endotoxin | 0.5–2% | Protein carrier in cell staining buffer — prevents non-specific antibody binding to Fc receptors on PBMC |
| Protein standard preparation | BSA Low Endotoxin or BSA pH 5.2 | Calibration curve | BCA and Bradford protein quantification standard. Matrix matching for cytokine standard curves. |
PBMC Isolation — Which Serum at Each Step
| Step | Serum | Note |
|---|---|---|
| Ficoll density gradient separation | No serum in Ficoll layer — use PBS or RPMI without serum | Serum in the Ficoll layer reduces separation efficiency |
| Wash steps after isolation | RPMI without serum or with 0.5% BSA Low Endotoxin | Remove residual Ficoll — minimal protein to prevent premature activation |
| Rest/recovery culture (2–24h post-isolation) | FBS Very Low Endotoxin ≤1 EU/mL or Human Serum AB HI at 5–10% | Overnight rest reduces isolation stress before stimulation — critical for low background ELISpot |
| Stimulation and assay culture | Same serum as rest culture — consistent throughout | Serum change between rest and stimulation introduces variability |
| Cryopreservation medium | 90% FBS Very Low Endotoxin or Human Serum AB HI + 10% DMSO | High serum concentration required for cryoprotection. VLE grade maintains PBMC viability and function post-thaw. |
Frequently Asked Questions
Why is standard FBS not suitable for ELISpot assays?
Standard FBS contains variable endotoxin levels — typically 10–100 EU/mL in unselected lots. Endotoxin activates monocytes and macrophages in PBMC preparations via TLR4, triggering non-specific IFN-γ, TNF-α and IL-6 secretion. In IFN-γ ELISpot assays this creates elevated background spot counts in unstimulated wells — reducing the signal-to-noise ratio and masking antigen-specific T cell responses. FBS Very Low Endotoxin ≤1 EU/mL eliminates this non-specific monocyte activation.
When is Human Serum AB HI preferred over FBS VLE for PBMC assays?
Human Serum AB HI is preferred when: (1) the assay measures a response that requires physiological relevance to the human immune environment — vaccine immunogenicity ELISpot, OPA, clinical immunomonitoring; (2) bovine xenogenic proteins could stimulate non-specific responses; (3) the donor's autologous serum is not available and a matched human matrix is needed. For routine cell culture and non-antigen-specific assays, FBS VLE is cost-effective and acceptable.
How does overnight rest improve ELISpot results?
PBMC isolation by Ficoll density gradient causes mechanical stress, temperature changes, and activation signals that prime cells for non-specific cytokine release. A 16–24 hour rest culture at 37°C in serum-containing medium allows this isolation-induced activation to subside before stimulation. Labs that rest PBMCs in VLE FBS or Human Serum AB HI consistently report lower background spot counts than those that stimulate immediately post-isolation.
What serum for PBMC cryopreservation?
90% FBS Very Low Endotoxin + 10% DMSO is the standard cryopreservation medium for PBMCs. High serum concentration (90%) provides the protein matrix needed for cryoprotection. VLE grade is specified because standard FBS endotoxin activates cells during the freeze-thaw cycle — reducing post-thaw viability and functional recovery. Human Serum AB HI at 90% is an alternative for xeno-free cryopreservation protocols.
Related Applications
| Application | Link |
|---|---|
| Cytotoxicity Assays (ADCC, CDC, ELISpot) | Cytotoxicity Assay Guide → |
| CAR-T Cell Manufacturing | CAR-T Manufacturing Guide → |
| Human Serum AB HI product page | Human Serum AB HI → |
| FBS Very Low Endotoxin | FBS Very Low Endotoxin → |
Technical enquiries, batch reservation: info@seamlessbio.de | +49 851 37932226